Regulation 13 Amendment of paragraph 19 of Schedule 2 to the principal Regulations

In paragraph 19 of Schedule 2 to the principal Regulations (applications in respect of pharmaceutical lists and the procedures to be followed – notification procedure for notifiable applications), after sub-paragraph (4) insert—

“(5)

A relevant HWB that is notified under sub-paragraph (1)(h) in relation to a consolidation application must make representations in writing about the application under sub-paragraph (4) which (in addition to any other matter about which they may wish to make representations) indicate whether, if the application were granted, in the opinion of the relevant HWB the proposed removal of premises from its pharmaceutical list would or would not create a gap in pharmaceutical services provision that could be met by a routine application—

(a)

to meet a current or future need for pharmaceutical services; or

(b)

to secure improvements, or better access, to pharmaceutical services.”.